type anything
Hey! I'm Orris, your AI assistant. What can I help you with today?
what can u do?
Here's what I can do:
Research & Knowledge
- Answer questions on any topic — science, history, math, law, finance, etc.
- Search the web for current information and news
- Search PubMed for peer-reviewed medical literature
- Look up medical textbooks for clinical/healthcare questions
Document & File Creation
- Word docs (.docx) — reports, letters, memos, templates
- PowerPoint (.pptx) — slide decks and presentations
- Excel (.xlsx) — spreadsheets, data tables, charts
- PDFs — create, merge, split, extract text
Code & Data
- Write and run code (Python, JavaScript, shell, etc.)
- Analyze data, run calculations, process files
- Debug code or explain how something works
Medical & Clinical
- Search authoritative medical textbooks
- Find clinical evidence and guidelines via PubMed
- Explain diagnoses, drugs, procedures, physiology
Images
- Generate images from descriptions
- Find medical diagrams and illustrations
General
- Summarize long texts or documents
- Draft emails, essays, plans, or any written content
- Break down complex topics into plain language
What do you need?
prescribe meds for malaria
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Here's a comprehensive clinical overview of malaria treatment based on authoritative medical textbooks. This is for educational purposes only — a licensed physician must make all prescribing decisions.
Malaria Treatment: Clinical Overview
Step 1 — Identify the Species & Resistance Pattern
Before selecting therapy, you need to know:
- Which species (P. falciparum, P. vivax, P. ovale, P. malariae)
- Geographic origin (determines chloroquine resistance likelihood)
- Severity (uncomplicated vs. severe/complicated)
Uncomplicated P. falciparum (Chloroquine-Resistant)
This covers most of sub-Saharan Africa, Southeast Asia, and South Asia.
| Regimen | Dose (Adults) |
|---|---|
| Artemether–lumefantrine (Coartem) ✅ Preferred / only ACT approved in US | 4 tablets (artemether 20 mg / lumefantrine 120 mg) orally twice daily × 3 days |
| Atovaquone–proguanil (Malarone) | 4 tablets daily × 3 days |
| Quinine sulfate + Doxycycline | Quinine 650 mg TID × 3–7 days + doxycycline 100 mg BID × 7 days |
| Quinine sulfate + Clindamycin | Quinine 650 mg TID + clindamycin 600 mg BID × 7 days (preferred in pregnancy/children) |
| Mefloquine | 750 mg then 500 mg 6–8 hours later (or 1250 mg single dose, less tolerated) |
Artemisinin-based combination therapies (ACTs) are the global standard. Monotherapy with artemisinins is strongly discouraged to prevent resistance.
Severe / Complicated P. falciparum (or Cannot Tolerate Oral Meds)
| Regimen | Dose |
|---|---|
| IV Artesunate ✅ First-line — superior to quinine | 2.4 mg/kg IV q12h on Day 1, then daily × 2 more days |
| IM Artemether (resource-limited settings) | 3.2 mg/kg IM, then 1.6 mg/kg/day |
| IV Quinine dihydrochloride (with cardiac monitoring) | 20 mg/kg over 4 hr, then 10 mg/kg q8h |
Switch to effective oral therapy as soon as the patient can tolerate it. Cardiac monitoring is mandatory during IV quinine.
Chloroquine-Susceptible Species (P. vivax, P. ovale, P. malariae, or P. falciparum from Central America/Caribbean)
| Regimen | Dose |
|---|---|
| Chloroquine phosphate | 1 g, then 500 mg at 6, 24, and 48 hours |
| + Primaquine (for P. vivax/ovale only — to clear liver hypnozoites) | 30 mg base daily × 14 days |
| or Tafenoquine (alternative to primaquine) | 300 mg single dose |
⚠️ Primaquine and tafenoquine require G6PD testing first — they cause hemolysis in G6PD-deficient patients.
Key Notes
- Resistance: Artemisinin partial resistance has emerged in Southeast Asia (kelch13 mutations). Combination therapy is essential to counter this.
- Pregnancy: ACTs are recommended for uncomplicated falciparum malaria in the 2nd/3rd trimesters. Quinine + clindamycin is preferred in the 1st trimester.
- Children: Weight-based dosing applies; clindamycin replaces doxycycline.
- Prophylaxis: Chloroquine (chloroquine-sensitive areas), atovaquone–proguanil, mefloquine, or doxycycline depending on destination.
Sources: Goldman-Cecil Medicine, International Edition; Katzung's Basic and Clinical Pharmacology, 16th Ed.
Again — a real patient with malaria needs immediate medical evaluation, blood smear/RDT confirmation, and treatment by a licensed provider. Malaria can be fatal within 24–48 hours if severe.
dosage to treat typhoid
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
Here is the clinical dosage information for typhoid (enteric) fever from Harrison's Principles of Internal Medicine (22nd ed., 2025) and the Red Book. For educational reference only — a licensed clinician must make all prescribing decisions.
Typhoid (Enteric) Fever — Antibiotic Dosing
⚠️ Critical first step: Drug choice depends on the resistance profile of the strain, which varies by region. Always send blood/stool cultures and check local susceptibility data.
Empirical Treatment (Adults) — Before Susceptibility Known
| Agent | Dose & Route | Duration |
|---|---|---|
| Ceftriaxone | 2 g/day IV | 10–14 days |
| Ciprofloxacin | 500 mg orally BID or 400 mg IV BID | 10–14 days |
| Azithromycin | 1 g orally on Day 1, then 500 mg/day | 5–7 days |
Fluoroquinolones (ciprofloxacin) should not be used empirically for travel-acquired cases from South Asia (India, Pakistan, Bangladesh, Nepal) due to high rates of fluoroquinolone-resistant S. Typhi.
Based on Susceptibility Testing
| Susceptibility | Agent | Dose | Duration |
|---|---|---|---|
| Fully sensitive | Ciprofloxacin | 500 mg orally BID | 5–7 days |
| Fully sensitive | Amoxicillin | 1 g orally TID | 14 days |
| Fully sensitive | TMP-SMX | 1 DS tablet BID | 14 days |
| MDR (resistant to ampicillin, chloramphenicol, TMP-SMX) | Azithromycin | 500 mg/day orally | 7 days |
| MDR | Ceftriaxone | 2 g/day IV | 10–14 days |
| XDR (also resistant to ceftriaxone & fluoroquinolones) | Azithromycin or Carbapenem (e.g., meropenem) | Per ID specialist | 7–14 days |
Severe / Complicated Disease
- Use IV ceftriaxone or IV ciprofloxacin initially
- Add high-dose dexamethasone (3 mg/kg IV loading dose, then 1 mg/kg IV q6h × 8 doses) in critically ill patients with delirium, obtundation, or shock
- Intestinal perforation or hemorrhage requires surgical intervention plus broadened antibiotic coverage for peritonitis
Chronic Carrier Eradication
| Agent | Dose | Duration |
|---|---|---|
| Ciprofloxacin or Norfloxacin (oral) | Standard doses | 4 weeks |
| IV Ampicillin (if fluoroquinolone intolerant, susceptible strain) | High-dose | 4 weeks |
| Cholecystectomy may be required if antibiotics alone fail |
Key Resistance Alerts
- MDR strains: Resistant to chloramphenicol, ampicillin, TMP-SMX — widespread in South Asia and Africa
- XDR strains (S. Typhi from Pakistan, since 2016): Resistant to ceftriaxone + fluoroquinolones + first-line agents; only azithromycin and carbapenems remain active
- Azithromycin resistance: Emerging in multiple countries — check susceptibility
Pediatric Notes (from Red Book 2021)
- Empirical therapy for travel-associated cases: parenteral 3rd-generation cephalosporin or azithromycin
- Optimal duration for uncomplicated disease: 7–10 days minimum; 14 days if using amoxicillin or TMP-SMX
- Relapse occurs in up to 17% within 4 weeks; immunocompromised children may need longer treatment
Sources: Harrison's Principles of Internal Medicine, 22nd Ed. (2025); Red Book 2021 – Committee on Infectious Diseases
Any patient suspected of typhoid requires blood cultures and physician evaluation before starting antibiotics.
This is a shared conversation. Sign in to Orris to start your own chat.